Tech-enabled DSUR literature review driven by biologit

Proven Results with biologit

At biologit, we are dedicated to supporting our clients with their pharmacovigilance needs. We recently supported a clinical biotech company by streamlining their DSUR literature review process to produce results in less than 5 days, and on budget. As a result of our cutting-edge platform and database, biologit was able to:

• Review over 10,000 articles

• Identify and remove 4,771 duplicates

• Pinpoint 16 relevant safety articles

  
  

Contact us to learn more about how we can support you.